Omalizumab (Xolair) for Food Allergy

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2024年 / 66卷 / 1699期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [21] Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis
    Lieberman, Jay A.
    Chehade, Mirna
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (01) : 78 - 84
  • [22] Omalizumab (xolair) in treatment resistant bullous pemphigoid
    Blake, S.
    Murrell, D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 20 - 20
  • [23] The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy
    Shaker, Marcus
    Anagnostou, Aikaterini
    Abrams, Elissa M.
    Lee, Michael
    Conway, Alexandra E.
    Blatman, Karen S. Hsu
    Oppenheimer, John
    Greenhawt, Matthew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (09):
  • [24] Omalizumab gives tolerance in patients with severe food allergy
    Mennini, M.
    Artesani, M. C.
    Dahdah, L.
    Pecora, V.
    Santamaria, F.
    Valluzzi, R.
    Fierro, V.
    Riccardi, C.
    Fiocchi, A.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (04) : E271 - E271
  • [25] A practical guide for implementing omalizumab therapy for food allergy
    Casale, Thomas B.
    Fiocchi, Alessandro
    Greenhawt, Matthew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (06) : 1510 - 1517
  • [26] Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy
    Hamilton, RG
    Marcotte, GV
    Saini, SS
    JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 303 (1-2) : 81 - 91
  • [27] A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
    Sampson, Hugh A.
    Leung, Donald Y. M.
    Burks, A. Wesley
    Lack, Gideon
    Bahna, Sami L.
    Jones, Stacie M.
    Wong, Dennis A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (05) : 1309 - U338
  • [28] Omalizumab (Xolair):: An anti-IgE antibody for asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1163): : 67 - 68
  • [29] Omalizumab (Xolair) in Children with Atopic Dermatitis: A Review Article
    Ghaffari, Javad
    Ghaffari, Negar
    JOURNAL OF PEDIATRICS REVIEW, 2018, 6 (01)
  • [30] A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of XOLAIR® (omalizumab) in peanut allergy (TOPS)
    Sampson, H. A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S117 - S117
12345